Podcasts

Gene Editing Complexities with Tom McCauley, PhD

Emily Walsh Martin, PhD - January 16, 2024

Tom McCauley, PhD (Omega Therapeutics) joins Emily Walsh Martin, PhD to explore the next generation of molecular therapeutics on the second episode of The Issue, available now on the ASGCT Podcast Network.

Follow the ASGCT Podcast Network wherever you listen to podcasts!

     

Episode 2 of The Issue on the ASGCT podcast network is an in-depth interview with Tom McCauley, PhD, CSO of Omega Therapeutics. Tom and Emily talk about his path from condensed matter physics to leading teams of scientists exploring the next generation of molecular therapeutics. They also dive into their mutual experience in the early days of in vivo gene editing and the challenges one faces with the complexities of these products, particularly before there is much of a roadmap for development. Finally, they dive into the recent public Ad Comm and ultimate approval of Casgevy and how we hope the industry continues to evolve and set standards as we move forward novel approaches.

Music by: https://www.steven-obrien.net/
--------------------------
Bright New Morning - Steven O'Brien

(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)

Related Articles

Podcasts

Setting Safety Parameters in Gene Therapy Trials with Thomas Wechsler

Listen to the Molecular Therapy Podcast - January 14, 2025
Podcasts

RNA Exon Editing with Ascidian Therapeutics' Drs. Robert Bell and Michael Ehlers

Listen to the latest Molecular Therapy Podcast! - January 07, 2025
Podcasts

Cell Therapy Development for Solid Tumors with AffyImmune's Sonal Gupta, MD, PhD

Listen to this episode of The Issue now! - December 10, 2024
Podcasts

Single-chain Antibody-directed Herpes Simplex Viruses with Joseph Glorioso, PhD

Listen to The Molecular Therapy Podcast - December 03, 2024